You are viewing: North America ECMO Machines Market analysis
Part of: ECMO Machines Market (Global)

The North America ECMO Machines Market was valued at $181.6 Million in 2025 and projected to reach to $233.7 Million by 2030, representing a compound annual growth rate of 5.2%. North America's ECMO machines market is positioned for steady growth, supported by an aging population with rising incidence of cardiac and respiratory failures.

North America ECMO Machines Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

North America ECMO Machines Market Trends and Insights

  • This steady expansion reflects Europe's advanced healthcare infrastructure, increasing prevalence of cardiac and respiratory failures, and growing adoption of extracorporeal membrane oxygenation technology across major medical centers.
  • Europe's aging population and rising incidence of COVID-19-related complications have further accelerated demand for ECMO devices in critical care settings. The European market benefits from strong regulatory frameworks, established reimbursement pathways, and significant investments in intensive care unit capabilities.
  • Europe's leading economies, including Germany, France, and the United Kingdom, are driving innovation and market penetration through enhanced clinical protocols and training programs.
  • Between 2025 and 2030, Europe is expected to see increased adoption of portable and miniaturized ECMO systems, improved patient outcomes, and expanded applications in both adult and pediatric populations..

Key Market Statistics

  • CAGR (2025-2030) 5.2% CAGR
  • Market Size, 2025 ~USD 181.6 Million
  • Forecast, 2030 ~USD 233.7 Million
  • Geography North America

North America ECMO Machines Market Overview

US Market Dominance :

The United States accounts for $160.69 million of North America's ECMO market, driven by advanced healthcare infrastructure, high prevalence of cardiac and respiratory conditions, and significant investment in critical care technologies.

Canadian Growth Opportunity :

Canada's ECMO market is valued at $53.51 million, with steady growth supported by universal healthcare access, increasing adoption in major medical centers, and rising awareness of extracorporeal membrane oxygenation therapies.

Regional CAGR Performance :

North America's ECMO machines market is projected to grow at a 5.2% CAGR from 2025 to 2030, slightly below the global average of 5.8%, reflecting mature market dynamics and established clinical adoption patterns.

Clinical Expansion Drivers :

Growth is fueled by increasing prevalence of heart failure, COVID-19 recovery protocols, expanding ICU capacity, and growing physician confidence in ECMO technology across North American hospitals and specialized cardiac centers.

North America ECMO Machines Market Dynamics

  • The region's well-established healthcare infrastructure, coupled with increasing adoption of advanced life support technologies, creates a favorable environment for market expansion.
  • Major medical centers across the US and Canada are investing in ECMO capabilities, driving demand for both equipment and trained personnel. The market is expected to benefit from ongoing clinical evidence supporting ECMO efficacy, reimbursement improvements, and technological innovations in device design and portability.
  • However, high equipment costs and limited availability of trained specialists may moderate growth rates compared to emerging markets.
  • Strategic partnerships between manufacturers and healthcare institutions will be critical for sustained market penetration through 2030..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Europe's ECMO machines market is valued at $181.6 million in 2025 and will reach $233.7 million by 2030, growing at a 5.2% CAGR.
    • Europe's advanced healthcare infrastructure and strong regulatory environment support steady market expansion and technology adoption.
    • Aging demographics and post-pandemic critical care demands are key drivers of ECMO adoption across European hospitals.
    • Europe is witnessing increased innovation in portable and miniaturized ECMO systems with expanding pediatric and adult applications.

    ECMO Machines Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR) (Application)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.8% from 2025 to 2030
    Largest Segment ADULT PATIENTS (Patient Type)
    Market Size Base Year (Billions) ~USD 0.65 (2025)
    Revenue Forecast (Billions) ~USD 0.86 (2030)
    Segments Covered Product, Type, Modality, Patient Type, Application, End User

    North America ECMO Machines Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Components
    • Machines

    By Type

    • Accessories
    • Cannulas
    • Controllers
    • Oxygenators
    • Pumps

    By Modality

    • Arteriovenous Ecmo
    • Venoarterial Ecmo
    • Venovenous Ecmo

    By Patient Type

    • Adult Patients
    • Neonates
    • Pediatric Patients

    By Application

    • Cardiac Applications
    • Extracorporeal Cardiopulmonary Resuscitation (Ecpr)
    • Respiratory Applications

    By End User

    • Academic & Research Institutions
    • Hospitals
    • Specialty Clinics

    Target Audience

    • Medical Device Manufacturers : ECMO equipment producers need North America-specific market data to optimize product development, pricing strategies, and distribution channels while navigating FDA regulations and competitive positioning in the US and Canadian markets.
    • Hospital & Healthcare Systems : Cardiac and critical care centers require market insights to justify ECMO program investments, benchmark utilization rates against peers, and plan capital equipment budgets aligned with regional demand forecasts.
    • Healthcare Investors & PE Firms : Investment professionals evaluating opportunities in medical technology and healthcare services need comprehensive North American market data to assess growth potential, competitive dynamics, and exit opportunities in the ECMO sector.
    • Consulting & Strategy Firms : Management consultants advising healthcare clients require detailed market analysis, trend forecasts, and competitive intelligence to develop go-to-market strategies and operational improvement recommendations for ECMO programs.
    • Government & Policy Organizations : Healthcare policy makers and regulatory bodies benefit from market data to inform reimbursement policies, clinical guidelines, and resource allocation decisions for critical care infrastructure across North America.

    Key Companies in the North America ECMO Machines Market

    CompanyHQOwnershipStrongest segments
    GETINGESwedenPublic CompanyAcute Care Therapies,Surgical Workflows,Life Science,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    TERUMO CORPORATIONJapanPublic CompanyCardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company,
    FRESENIUS MEDICAL CARE AGGermanyPublic CompanyDialysis services (outpatient and in-hospital ESRD/acute),Dialysis machines, cyclers, and water treatment systems,Dialysis consumables and solutions,
    LIVANOVA PLCUnited KingdomPublic CompanyCardiopulmonary (heart-lung machines, oxygenators, autotransfusion, perfusion tubing, cannula, services),Neuromodulation (VNS Therapy for epilepsy and depression, aura6000 development),
    NIPROJapanPublic CompanyDialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products, functional products,Pharmaceutical-Related (CDMO for injectables and oral drugs, kit products),
    WEIGAO GROUP CO., LTD.ChinaPublic CompanyMedical Device Products (infusion, clinical nursing, perioperative, urinary, rehab, extracorporeal circulation),Orthopedic Products (spine, joint, trauma, sports medicine, bone repair, spinal endoscope),Pharma Packaging Products (prefilled systems, packaging consumables, automatic drug delivery),
    ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
    MICROPORT SCIENTIFIC CORPORATIONChinaPublic CompanyCardiovascular Devices,Orthopedics Devices,Cardiac Rhythm Management,

    GETINGE

    Getinge is a Swedish public company founded in 1904 that employs 11,754 people and operates in the medical technology sector.

    MEDTRONIC

    Medtronic is a public company headquartered in Ireland, founded in 1949, with approximately 95,000 employees specializing in medical devices and healthcare solutions.

    TERUMO CORPORATION

    Terumo Corporation is a Japanese public company established in 1921 with 30,591 employees, operating in the medical device and healthcare industry.

    FRESENIUS MEDICAL CARE AG

    Fresenius Medical Care AG is a German public company founded in 1996 with 108,165 employees, providing dialysis and renal care services globally.

    LIVANOVA PLC

    LivaNova PLC is a United Kingdom-based public company founded in 2015 with 3,300 employees, focused on neuromodulation and cardiac surgery solutions.

    NIPRO

    Nipro is a Japanese public company established in 1947 with 38,593 employees, manufacturing medical devices and pharmaceutical products.

    WEIGAO GROUP CO., LTD.

    Weigao Group Co., Ltd. is a Chinese public company founded in 1988 with 13,307 employees, specializing in medical device manufacturing.

    ABBOTT

    Abbott is a United States-based public company founded in 1888 with 115,000 employees, operating across diagnostics, medical devices, nutrition, and pharmaceuticals.

    MICROPORT SCIENTIFIC CORPORATION

    MicroPort Scientific Corporation is a Chinese public company established in 1998 with 6,547 employees, developing and manufacturing medical devices.

    North America vs. other regions

    HowNorth America compares to the other 3 regional blocs covered in this market.

    Global
    ~USD 343 Million · 5.6% wtd CAGR ·
    Europe
    ~USD 16.93 Million · 7.9% wtd CAGR ·
    Asia Pacific
    ~USD 20.28 Million · 6.9% wtd CAGR ·
    Middle East & Africa
    ~USD 65.7 Million · 6% wtd CAGR ·

    Countries within North America - compare and drill down

    Country2025 size (native)
    USUSD 160.69 Million
    CanadaUSD 53.51 Million

    Country market size visualization

    US
    USD 160.69 Million
    Canada
    USD 53.51 Million

    Reasons to Buy this Report

    • Market Size & Segmentation Data : Access detailed market valuations for the US ($160.69M) and Canada ($53.51M), with granular breakdowns by hospital type, patient demographics, and clinical applications specific to North American healthcare systems.
    • Competitive Landscape Analysis : Identify leading ECMO manufacturers, market share distribution, and competitive strategies tailored to North American regulatory requirements, reimbursement models, and hospital procurement practices.
    • Growth Forecasts & Trend Analysis : Leverage 5-year projections (2025-2030) with 5.2% CAGR to inform strategic planning, investment decisions, and market entry strategies for North American healthcare providers and device manufacturers.
    • Regulatory & Reimbursement Insights : Understand FDA approval pathways, Medicare/Medicaid coverage policies, provincial health authority requirements in Canada, and insurance reimbursement trends affecting ECMO adoption and pricing strategies.
    • Clinical Adoption Drivers : Discover key factors driving ECMO utilization in North American ICUs, including patient outcomes data, physician adoption rates, training infrastructure, and emerging clinical indications beyond traditional cardiac/respiratory support.

    Frequently asked questions

    What is the current size of Europe's ECMO machines market?

    Europe's ECMO machines market is valued at $181.6 million in 2025.

    What is the projected market size for Europe's ECMO machines by 2030?

    Europe's ECMO machines market is projected to reach $233.7 million by 2030.

    What is the growth rate of Europe's ECMO machines market?

    Europe's ECMO machines market is expected to grow at a compound annual growth rate (CAGR) of 5.2% from 2025 to 2030.

    Which European countries are leading the ECMO machines market?

    Germany, France, and the United Kingdom are among Europe's leading markets for ECMO machines, driven by advanced healthcare infrastructure and significant critical care investments.

    What factors are driving growth in Europe's ECMO machines market?

    Key drivers include Europe's aging population, increasing cardiac and respiratory failure cases, post-pandemic critical care demands, strong regulatory frameworks, and innovation in portable ECMO systems.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size of the ECMO machines market. Exhaustive secondary research was done to collect information on the ECMO market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the ECMO market.

    Secondary Research

    This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the ECMO market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the ECMO market. Primary sources from the demand side included hospitals, academic & research institutions, specialty clinics, researchers, lab technicians, purchase managers, and stakeholders in corporate & government bodies.

    The following is a breakdown of the primary respondents:

    ECMO Machines Market

    Note 1: C-level primaries include CEOs, COOs, and CTOs.

    Note 2: Others include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ECMO market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    ECMO Machines Market

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ECMO machines and components. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    An ECMO machine acts as an artificial heart and lung for a patient whose heart or lungs cannot provide enough blood flow or oxygen into the blood. ECMO is used after other methods of supporting the heart and lungs do not work. The goal of ECMO is to let the heart and lungs recover while the patient is supported by the ECMO machine.

    Stakeholders

    • Manufacturers of ECMO Machine Products and Related Devices
    • Suppliers and Distributors of ECMO Machine Devices
    • Hospitals, Clinics, and Medical Colleges
    • Medical Device Procurement Agencies
    • Government Bodies/Municipal Corporations
    • Business Research and Consulting Service Providers
    • Venture Capitalists
    • US Food and Drug Administration (US FDA)
    • European Union (EU)

    Report Objectives

    • To define, describe, and forecast the oxygen concentrators market based on product, modality, patient type, application, end user, and region  
    • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall oxygen concentrators market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the oxygen concentrators market in six regions, namely, North America (US and Canada), Europe (Germany, UK, France, Spain, Italy, and Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), Middle East & Africa, and GCC Countries
    • To strategically profile the key players in the global market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

    Get the Full ECMO Machines Market Report

    Full forecast, segment splits, and company analysis for all ECMO Machines Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status